BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34840074)

  • 1. The type III secretion system effector network hypothesis.
    Sanchez-Garrido J; Ruano-Gallego D; Choudhary JS; Frankel G
    Trends Microbiol; 2022 Jun; 30(6):524-533. PubMed ID: 34840074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmonella, E. coli, and Citrobacter Type III Secretion System Effector Proteins that Alter Host Innate Immunity.
    El Qaidi S; Wu M; Zhu C; Hardwidge PR
    Adv Exp Med Biol; 2019; 1111():205-218. PubMed ID: 30411307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NleB/SseK effectors from
    El Qaidi S; Chen K; Halim A; Siukstaite L; Rueter C; Hurtado-Guerrero R; Clausen H; Hardwidge PR
    J Biol Chem; 2017 Jul; 292(27):11423-11430. PubMed ID: 28522607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type Three Secretion System in Attaching and Effacing Pathogens.
    Gaytán MO; Martínez-Santos VI; Soto E; González-Pedrajo B
    Front Cell Infect Microbiol; 2016; 6():129. PubMed ID: 27818950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III secretion system effectors form robust and flexible intracellular virulence networks.
    Ruano-Gallego D; Sanchez-Garrido J; Kozik Z; Núñez-Berrueco E; Cepeda-Molero M; Mullineaux-Sanders C; Naemi Baghshomali Y; Slater SL; Wagner N; Glegola-Madejska I; Roumeliotis TI; Pupko T; Fernández LÁ; Rodríguez-Patón A; Choudhary JS; Frankel G
    Science; 2021 Mar; 371(6534):. PubMed ID: 33707240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EspZ of enteropathogenic and enterohemorrhagic Escherichia coli regulates type III secretion system protein translocation.
    Berger CN; Crepin VF; Baruch K; Mousnier A; Rosenshine I; Frankel G
    mBio; 2012; 3(5):. PubMed ID: 23033475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota and Pathogen Proteases Modulate Type III Secretion Activity in Enterohemorrhagic Escherichia coli.
    Cameron EA; Curtis MM; Kumar A; Dunny GM; Sperandio V
    mBio; 2018 Dec; 9(6):. PubMed ID: 30514785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An intra-bacterial activity for a T3SS effector.
    El Qaidi S; Scott NE; Hays MP; Geisbrecht BV; Watkins S; Hardwidge PR
    Sci Rep; 2020 Jan; 10(1):1073. PubMed ID: 31974499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the Tol-Pal system in the Type III secretion system and flagella-mediated virulence in enterohemorrhagic Escherichia coli.
    Hirakawa H; Suzue K; Takita A; Awazu C; Kurushima J; Tomita H
    Sci Rep; 2020 Sep; 10(1):15173. PubMed ID: 32968151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type III secretion system effector EspO of enterohaemorrhagic Escherichia coli inhibits apoptosis through an interaction with HAX-1.
    Chatterjee S; Lekmeechai S; Constantinou N; Grzybowska EA; Kozik Z; Choudhary JS; Berger CN; Frankel G; Clements A
    Cell Microbiol; 2021 Sep; 23(9):e13366. PubMed ID: 34021690
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Krekhno Z; Woodward SE; Serapio-Palacios A; Peña-Díaz J; Moon KM; Foster LJ; Finlay BB
    Gut Microbes; 2024; 16(1):2308049. PubMed ID: 38299318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage Transcription Factor Cro Regulates Virulence Gene Expression in Enterohemorrhagic Escherichia coli.
    Hernandez-Doria JD; Sperandio V
    Cell Host Microbe; 2018 May; 23(5):607-617.e6. PubMed ID: 29746832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attachment of Enterohemorrhagic Escherichia coli to Host Cells Reduces O Antigen Chain Length at the Infection Site That Promotes Infection.
    Liu B; Qian C; Wu P; Li X; Liu Y; Mu H; Huang M; Zhang Y; Jia T; Wang Y; Wang L; Zhang X; Huang D; Yang B; Feng L; Wang L
    mBio; 2021 Dec; 12(6):e0269221. PubMed ID: 34903041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli.
    Yen H; Karino M; Tobe T
    Front Cell Infect Microbiol; 2016; 6():89. PubMed ID: 27617233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection.
    Serapio-Palacios A; Finlay BB
    Curr Opin Microbiol; 2020 Apr; 54():67-76. PubMed ID: 32058947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assay for Type III Secretion in Escherichia coli.
    Mitrovic B; Sal-Man N
    Methods Mol Biol; 2022; 2427():37-46. PubMed ID: 35619023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.
    Arbeloa A; Oates CV; Marchès O; Hartland EL; Frankel G
    Infect Immun; 2011 Mar; 79(3):1067-76. PubMed ID: 21189318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enterohemorrhagic Escherichia coli effector protein NleF binds mammalian Tmp21.
    Olsen RL; Echtenkamp F; Cheranova D; Deng W; Finlay BB; Hardwidge PR
    Vet Microbiol; 2013 May; 164(1-2):164-70. PubMed ID: 23434013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of COPII trafficking is important for intestinal epithelial tight junction disruption during enteropathogenic Escherichia coli and Citrobacter rodentium infection.
    Thanabalasuriar A; Kim J; Gruenheid S
    Microbes Infect; 2013; 15(10-11):738-44. PubMed ID: 23747681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmonella SPI-2 Type III Secretion System Effectors: Molecular Mechanisms And Physiological Consequences.
    Jennings E; Thurston TLM; Holden DW
    Cell Host Microbe; 2017 Aug; 22(2):217-231. PubMed ID: 28799907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.